European Pharmaceutical Review

MARCH 31, 2023

“The access to increased capital… could allow for the potential for biopharmaceutical companies to improve investment in the development of therapies.” billion in total venture financing raised from 2010 to 2022 for drug development In 2018 alone, the company invested over $400 million in venture financing.

Biopharma 91

Biopharma Pharma Networking Marketing 91

Medico Reach

AUGUST 1, 2022

Venture capital is the lifeblood of breakthrough medical technologies. Whether you are a start-up looking for investment or are interested in working in venture capital (VC), the worldwide biopharma and MedTech industries are growing. As per Forbes , another $37B in mergers of biopharma firms was recorded.

Biopharma 52

Biopharma Healthcare Healthcare Specialization 52

pharmaphorum

OCTOBER 14, 2022

has announced a $168 million Series B financing, led by global venture capital firm General Catalyst, an active investor in the healthcare sector. The Series B financing includes participation from all Series A investors and new investment from Fidelity Management & Research Company and T.

Engineering 89

Engineering Medicine Electronics Healthcare 89

Pharmaceutical Technology

JUNE 12, 2023

Clinical-stage biotechnology firm Eccogene has raised $25.23m (CNY180m) in a Series B financing round to support the development of its clinical-stage metabolic pipeline. New investors Elikon Venture, YuFu Investment, Rockbleu Capital and Huajin Capital have also participated in the financing round.

Distribution 59

Distribution Patients Healthcare Healthcare 59

PM360

DECEMBER 20, 2023

The longer that investment remains at suppressed levels, the more attritional the industry will be. This is not necessarily a bad thing—few drugs that enter clinical trials eventually gain approval—so concentration of investment around fewer companies, platforms, and assets that are more differentiated is better for long-term innovation.

Biopharma 111

Biopharma Pharma Marketing Management 111

Pharmaceutical Technology

AUGUST 22, 2022

Merchant Health, a healthcare private equity (PE) fund of China Merchants Groups, led the financing round together with its sister fund China Merchants Capital and China Merchants Securities Investments.

Manufacturing 52

Manufacturing Pharmaceutical Marketing Medicine 52

Pharmaceutical Technology

APRIL 21, 2023

It brings the total capital raised by the company to $175m. Led by new investor Kinnevik, the Series B1 financing round has also seen participation from another new investor, Henry R Kravis, co-founder of private equity firm KKR. Existing investors include Wireframe, True Ventures, FPV and Dimension.

Medicine 59

Medicine Marketing 59

MedCity News

JUNE 16, 2023

Venture capital and other startup investment in the U.S. Market analysts CB Insights similarly tracked private investment last year in U.S. Market analysts CB Insights similarly tracked private investment last year in U.S. The consensus is 2022 was a challenging year for digital health companies. billion in 2021.

Pharma 119

Pharma Food and Drug Administration Recruitment Pharmacology 119

Pharmaceutical Technology

MAY 4, 2023

Magenta Therapeutics has signed a definitive merger agreement to combine its business with clinical-stage biotechnology firm Dianthus Therapeutics. The consolidated firm will run under the Dianthus Therapeutics brand and trade on the Nasdaq under the ‘DNTH’ ticker symbol.

Management 52

Management Healthcare Healthcare 52

PM360

DECEMBER 20, 2023

How can biotech companies successfully raise funds in an environment where investment in the industry is headed for a third straight year of decline? But that doesn’t mean opportunities for biotech companies to inject some much-needed capital are completely nonexistent. and 10X Capital Venture Acquisition Corp.

Management 109

Management Marketing Healthcare Healthcare 109

European Pharmaceutical Review

SEPTEMBER 7, 2023

Overall, “[it] will enable British companies to collaborate with their European counterparts on research projects, as well as allowing them to access vital EU research and innovation funding,” declared Helen Brain, Head of Health and Life Sciences at law firm Square One Law. This growth was largely driven by venture capital investment.

Government 77

Government Competition Pharmaceutical Manufacturing 77

Legacy MEDSearch

AUGUST 9, 2023

million Series B investment led by Eclipse. Additional participating investors include Intuitive Ventures and Puma Venture Capital, a new firm founded by Amit Hazan, a veteran Wall Street medical technology analyst, and Dr. Vipul Patel, a renowned robotic surgeon who has performed more robotic procedures than any other surgeon worldwide.

Medical 52

Medical Patients Recruitment Engineering 52

Clarivate

FEBRUARY 8, 2022

In this episode of Conversations in Healthcare , Naveed Saddiqi from Novo Ventures discusses how their investment strategy involved during the pandemic. . In collaboration with One Nucleus’ OnHelix conference, Mike Ward spoke with Naveed Saddiqi, a senior partner at Novo Ventures.

Healthcare 52

Healthcare Healthcare Management Doctors 52

pharmaphorum

DECEMBER 14, 2022

Morgan Asset Management, dubbed Life Sciences Private Capital. The team will be led by Dr Stephen Squinto in the role of chief investment officer, backed up by co-managing partners Dr Gaurav Gupta and Anya Schiess. Squinto and Gupta come from OrbiMed Advisors and Schiess joins from Healthy Ventures.

Consulting 95

Consulting Pharma Healthcare Healthcare 95

pharmaphorum

AUGUST 11, 2022

The top-up comes from Intel Capital, the strategic investment arm of chipmaker Intel, and has been announced alongside two new additions to Biofourmis’ board of directors. The upscaled financing comes during a downturn in digital health investment. billion, a sharp reduction on the $14.7

Healthcare 52

Healthcare Healthcare Management Marketing 52

pharmaphorum

OCTOBER 10, 2022

The digital health sphere reached the peak of its investment in 2021, with a total venture funding of $29.1 Investments surged following the pandemic, with investors having a supercharged interest in health tech, particularly telemedicine. Funding has been able to support a variety of different digital food allergy innovations.

Food 102

Food Healthcare Healthcare Electronics 102

Pharmaceutical Technology

OCTOBER 18, 2022

held in the trust of EBAC and nearly $80m in upsized private investment in public equity (PIPE) and private investment. The firm will have its headquarters at the present Oculis office at the EPFL Innovation Park in Lausanne in the country. The deal is also expected to offer proceeds comprising nearly $127.5m

Specialization 59

Specialization Management Medical Pharmaceutical 59

Pharmaceutical Technology

DECEMBER 19, 2022

Financing recognises companies and institutions that have raised significant capital during the research period whether it be through corporate finance, the capital markets or fund raising. Investments. The category also includes companies that have made significant investments into their R&D processes.

Marketing 52

Marketing Sales Strategy Manufacturing Pharmaceutical 52

pharmaphorum

AUGUST 23, 2022

UK biotech Mereo BioPharma is attempting to face down a revolt by Rubric Capital Management – its largest shareholder holding around 14% of the company – which is agitating for changes to its board and strategic direction.

Biopharma 52

Biopharma Government FDA Management 52

Pharmaceutical Technology

DECEMBER 22, 2022

Financing recognises companies and institutions that have raised significant capital during the research period whether it be through corporate finance, the capital markets or fund raising. Investments. GlaxoSmithKline (GSK) wins the Investments award following its announcement of significant investment of $1.2

Medicine 52

Medicine Marketing Pharmaceutical Manufacturing 52

PM360

JULY 26, 2023

To get a better grasp on what eventual AI regulations could and should look like, PM360 spoke with Nick Adams, Founding Partner at Differential Ventures. The repercussion is that the business performance will also suffer or not generate a return on investment.

Government 95

Government Marketing Management Education 95

Medico Reach

JANUARY 2, 2023

With a broad scope of products and software in this sector, companies must capitalize on its exponential growth. With over a billion people experiencing different disabilities, assistive technology in healthcare has become a vital investment facet. . Communication firms. Wheelchairs. Memory aids. Optical gadgets. Prostheses.

Healthcare 75

Healthcare Healthcare Medical Government 75

Clarivate

APRIL 24, 2023

Five months after outbidding Amazon to purchase the Signify Health home health platform—and just a month after CVS’ investment arm funneled $100 million to Carbon Health, a hybrid primary/virtual company with more than 125 brick and mortar locations—CVS Health announced it was closing in on a $10.6

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Pharmaceutical Technology

DECEMBER 27, 2022

Generally speaking, the overall environment has been a little bit more volatile for dealmaking, and you’ve seen that not just in corporate venture capital,” says Subin Baral, Ernst & Young’s Global Deals Leader for Life Sciences. This volatility has also reduced the appetites of investors and biotechs for riskier deals.

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52

Nixon Gwilt Law

NOVEMBER 17, 2022

For the last two years, investment in health innovation has been relatively easy to find for founders. This is more than M&A talk, this is truly collaboration between companies--marketplace approaches, joint ventures, global collaborative learning (check out ECHAlliance Group (European Connected Health Alliance). So dry here.

Healthcare 52

Healthcare Healthcare Government Marketing 52

CloserIQ

NOVEMBER 23, 2018

“A candidate with the right personality for a sales role is worth the investment of time and labor it takes to train them to become a great salesperson.” Venture firms are making more hires (Business Insider). ” Alternative exits: The rise of secondary deals in venture capital (Pitchbook).

Sales 53

Sales Recruitment Prospecting Management 53

pharmaphorum

OCTOBER 26, 2022

These results highlight the need to invest in therapeutic innovation as well as diagnostics and newborn screening. They also help justify increased governmental investment to ensure broader patient access to safe and effective therapies and policy proposals that reflect the unique challenges rare disease patients and companies often face.”.

Patients 73

Patients Pharma Consulting Transportation 73

CloserIQ

SEPTEMBER 17, 2019

Investment from reputable VC firms and angel investors. Does this investor (or venture capital fund) have a track record of backing successful companies? Stage of the startup in terms of size, customer base, and investments. Look at the company’s core data: revenue, profits, investments, and number of employees.

Sales 92

Sales Prospecting Marketing Consulting 92

Nixon Gwilt Law

DECEMBER 16, 2021

Katherine also says, “The amount of money being invested in the health tech, digital health and telehealth space is only going to go up, because there will be more evidence of its need based on two years of exponential growth.” to the Firm in part to address the influx of SaMD client needs. Up from here? (So

Healthcare 52

Healthcare Healthcare Food and Drug Administration Ethics 52

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. Introducing Angelini Ventures. Angelini Ventures isn’t a typical corporate venture capital firm.

Healthcare 105

Healthcare Healthcare Patients Management 105

European Pharmaceutical Review

AUGUST 24, 2023

Mergers and acquisitions (M&A) will play a critical role in how companies adapt and as a result portfolio prioritisation is front and centre of the capital allocation strategies, he explained. Venture funding in 2022 came in at about $13.7 This represented the largest ever venture round in the history of the industry.

Biopharma 81

Biopharma Pharmaceutical Pharma Medical 81

CloserIQ

SEPTEMBER 17, 2019

Investment from reputable VC firms and angel investors. Does this investor (or venture capital fund) have a track record of backing successful companies? Stage of the startup in terms of size, customer base, and investments. Look at the company’s core data: revenue, profits, investments, and number of employees.

Sales 52

Sales Prospecting Marketing Consulting 52

Legacy MEDSearch

OCTOBER 18, 2022

The company secured $8 million in capital to fund pre-clinical studies with the FDA and to scale up prototypes of its neural implants “as soft as the brain.” The capital will also be used to expand the Axoft team. We accelerate the path to market for Tough Tech companies through the combination of capital, infrastructure, and network.

FDA 98

FDA Engineering Electronics Recruitment 98

MedCity News

JUNE 12, 2023

Many businesses are now taking a second, and even third look, at their current strategy – especially now, as venture capitalists are posing the question, “how are you different than Pear Therapeutics?” In 2019, it decided to invest some of its profits into building a DTx pipeline.

Food and Drug Administration 102

Food and Drug Administration Prescription Government FDA 102

CloserIQ

JANUARY 16, 2019

Investing time and effort to improve sales effectiveness will pay big dividends. Just getting the correct talent can double overall firm revenue with no incremental headcount.”. How to Give Effective Performance Feedback Frameworks and Best Practices (Liz Cain of Openview Venture Partners). Managing Teams.

Sales 49

Sales Recruitment Prospecting Sales process 49

pharmaphorum

AUGUST 31, 2022

Though there are still few commercial treatments, in terms of therapeutic potential, Ben Hargreaves finds that companies and investment firms are pushing for this number, and the overall market, to grow rapidly in the coming years. After a recent approval, there are now three gene therapies available on the US market.

FDA 78

FDA Marketing Safety Patients 78

Medgadget

FEBRUARY 17, 2023

Check out a short video from Human Xtensions introducing the HandX system: Human Xtensions is somewhat unique for an Israeli medtech firm, as it is independent, is publicly traded, with a portfolio of patents, has a product on the market, but which has not been acquired by one of the large players in the industry.

Physicians 80

Physicians Engineering Side effects Leads 80